Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Comparative Study to Evaluate the Added Value of Logotherapy in the Psychological Support of Patients With Primary Breast Cancer

NCT07267572 is registered in ClinicalTrials.gov with Elsan as lead sponsor.

NCT NCT07267572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07267572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Comparative Study to Evaluate the Added Value of Logotherapy in the Psychological Support of Patients With Primary Breast Cancer
Lead sponsor
Elsan
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
November 1, 2028
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer